System for Electronic Document Analysis and Retrieval

Eloro Resources Announces C$12,900,000 Bought Deal Financing

Tuesday, March 2, 2021 - 9:32pm

The Units will be offered by way of a short form prospectus to be filed in all provinces of Canada, except Qubec.

Key Points: 
  • The Units will be offered by way of a short form prospectus to be filed in all provinces of Canada, except Qubec.
  • Eloro is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.
  • Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloros website and under its filings on SEDAR.
  • La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometres.

Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results

Tuesday, March 2, 2021 - 9:02pm

TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2020.

Key Points: 
  • TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2020.
  • For the period ended September 30, 2020 and for all prior periods, Profound presented its financial statements in Canadian dollars.
  • Fourth quarter 2020 selling and distribution expenses increased by 79% to approximately $1.7 million, compared with $977,000 in the fourth quarter of 2019.
  • For complete financial results, please see Profounds filings at www.sedar.com , www.sec.gov and on the Companys website at www.profoundmedical.com under Financial in the Investors section.

Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021

Tuesday, March 2, 2021 - 9:02pm

The live conference call can also be accessed through a link on the Investor Relations section of Aptoses website at https://www.aptose.com/investors/news-events/ir-calendar.

Key Points: 
  • The live conference call can also be accessed through a link on the Investor Relations section of Aptoses website at https://www.aptose.com/investors/news-events/ir-calendar.
  • An archived version of the webcast along with a transcript will be available on the companys website for 30 days.
  • The press release, the financial statements and the managements discussion and analysis for the year and quarter ended December 31, 2020 will be available on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml.
  • Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology.

EMX Royalty Provides an Update for Timok Royalty Property and Files a Technical Report on SEDAR

Tuesday, March 2, 2021 - 11:30am

EMX holds an uncapped 0.5% net smelter return ("NSR") royalty on Timok's Brestovac license, which covers the Cukaru Peki copper-gold development project.

Key Points: 
  • EMX holds an uncapped 0.5% net smelter return ("NSR") royalty on Timok's Brestovac license, which covers the Cukaru Peki copper-gold development project.
  • In addition to the original agreement covering EMX's royalty interest in the Timok Project's Brestovac license, which has already been filed by EMX on SEDAR (see EMX News Release dated October 5, 2020), EMX has now filed on SEDAR a technical report, "NI 43-101 Technical Report - Timok Copper-Gold Project Royalty, Serbia" dated February 26, 2021 by Mineral Resource Management LLC.
  • EMX congratulates Zijin on its rapid progress in developing the Timok Project, and looks forward to new advancements as the work programs progress.
  • The Company's common shares are listed on the NYSE American Exchange and TSX Venture Exchange under the symbol EMX.

Baytex Energy Files 2020 Year-End Disclosure Documents

Monday, March 1, 2021 - 11:26pm

CALGARY, Alberta, March 01, 2021 (GLOBE NEWSWIRE) -- Baytex Energy Corp. (Baytex) (TSX:BTE) announces the filing of its Annual Information Form for the year ended December31, 2020 (the AIF) with the Canadian securities regulatory authorities on the System for Electronic Analysis and Retrieval (SEDAR).

Key Points: 
  • CALGARY, Alberta, March 01, 2021 (GLOBE NEWSWIRE) -- Baytex Energy Corp. (Baytex) (TSX:BTE) announces the filing of its Annual Information Form for the year ended December31, 2020 (the AIF) with the Canadian securities regulatory authorities on the System for Electronic Analysis and Retrieval (SEDAR).
  • The AIF contains reserves data and other oil and gas information as required by National Instrument 51-101 Standards of Disclosure for Oil and Gas Activities of the Canadian Securities Administrators.
  • On February 24, 2021, Baytex also filed its Audited Consolidated Financial Statements for the year ended December 31, 2020 and related Managements Discussion and Analysis on both SEDAR and EDGAR.
  • Baytex Energy Corp. is an oil and gas corporation based in Calgary, Alberta.

GoldMining Announces Filing of Financial Statements, MD&A, Annual Information Form and Annual Report on Form 40-F

Monday, March 1, 2021 - 10:18pm

VANCOUVER, BC, March 1, 2021 /PRNewswire/ - GoldMining Inc. (the "Company") (TSX: GOLD) (NYSE AMERICAN: GLDG)announces the filing of its annual financial statements, management's discussion and analysis, annual information form for the year ended November 30, 2020 (the "Annual Filings") and its annual report on Form 40-F (the "Form 40-F").

Key Points: 
  • VANCOUVER, BC, March 1, 2021 /PRNewswire/ - GoldMining Inc. (the "Company") (TSX: GOLD) (NYSE AMERICAN: GLDG)announces the filing of its annual financial statements, management's discussion and analysis, annual information form for the year ended November 30, 2020 (the "Annual Filings") and its annual report on Form 40-F (the "Form 40-F").
  • The Annual Filings, which include information regarding the Company's financial position, operations and projects for the fiscal year, are available under the Company's profile at www.sedar.com and on EDGAR at www.sec.gov/EDGAR and on the Company's website at www.goldmining.com .
  • GoldMining Inc. is a public mineral exploration company focused on the acquisition and development of gold assets in the Americas.
  • Additionally, GoldMining owns a 75% interest in the Rea Uranium Project, located in the Western Athabasca Basin of Alberta, Canada.

CEMATRIX Announces Public Offering of Units Co-Led by Gravitas Securities and Clarus Securities

Monday, March 1, 2021 - 9:47pm

The Offering is being conducted on a commercially reasonable agency basis by a syndicate of agents led by Gravitas Securities Inc. and Clarus Securities Inc., as co-lead agents and bookrunners, on behalf of a syndicate of agents (collectively, the "Agents").

Key Points: 
  • The Offering is being conducted on a commercially reasonable agency basis by a syndicate of agents led by Gravitas Securities Inc. and Clarus Securities Inc., as co-lead agents and bookrunners, on behalf of a syndicate of agents (collectively, the "Agents").
  • Each Warrant will be exercisable for one Common Share at a price of $0.81, for a period of 24 months following closing of the Offering.
  • The closing of the Offering is anticipated to occur on March 15, 2021 or such other date as the Company and the Agents may agree.
  • A copy of the preliminary short form prospectus is available under the Company's profile at www.sedar.com or by request to Gravitas Securities Inc. at syndication@gravitassecurities.com or Clarus Securities Inc. at nmonjes@clarussecurities.com .

MediPharm Labs Announces $20 million Bought Deal Equity Financing

Monday, March 1, 2021 - 9:33pm

The Underwriters are to be paid a cash commission equal to 6% of the gross proceeds of the Offering (3.0% on presidents list investors).

Key Points: 
  • The Underwriters are to be paid a cash commission equal to 6% of the gross proceeds of the Offering (3.0% on presidents list investors).
  • As a global leader, MediPharm Labs has completed commercial exports to Australia and has fully commercialized its wholly-owned Australian extraction facility.
  • Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs filings, available on the SEDAR website at www.sedar.com.
  • Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

Early Warning Report for Synex International Inc.

Monday, March 1, 2021 - 1:00pm

The Purchased Shares were acquired through normal course purchases through the facilities of the Toronto Stock Exchange for $0.25 per Purchased Share in cash, for an aggregate amount equal to C$50,000.

Key Points: 
  • The Purchased Shares were acquired through normal course purchases through the facilities of the Toronto Stock Exchange for $0.25 per Purchased Share in cash, for an aggregate amount equal to C$50,000.
  • This press release is being issued pursuant to National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues which requires a report to be filed under the Issuer's profile on SEDAR ( www.sedar.com ) containing additional information respecting the foregoing matters.
  • The Issuer's head office is located at 400 - 1444 Alberni Street, Vancouver, British Columbia, Canada, V6G 2Z4.
  • For inquiries or a copy of the related early warning report required under Canadian provincial securities legislation, a copy of which has also been filed on www.sedar.com , please contact:

Verde Grows 103% in 2020, Achieves Sales Target and Provides Corporate Update

Monday, March 1, 2021 - 12:00pm

Audited financial results for Q4 2020 and FY 2020 will be reported and filed on SEDAR on March 30, 2021.

Key Points: 
  • Audited financial results for Q4 2020 and FY 2020 will be reported and filed on SEDAR on March 30, 2021.
  • In November 2019, the Company had announced a revenue target of R$32 million for 2020.
  • On November 16, 2020, Verde revised its target, raising it by 10%.
  • We know that 2020 was a challenging year for everyone because of Covid-19, especially in heavily affected Brazil.